|1.||David, Sascha: 16 articles (07/2015 - 01/2008)|
|2.||Kümpers, Philipp: 16 articles (03/2013 - 01/2008)|
|3.||Haller, Hermann: 14 articles (07/2015 - 01/2008)|
|4.||Kielstein, Jan T: 11 articles (07/2015 - 01/2008)|
|5.||Lukasz, Alexander: 11 articles (01/2014 - 01/2008)|
|6.||Liles, W Conrad: 10 articles (01/2015 - 01/2011)|
|7.||De Palma, Michele: 8 articles (02/2015 - 06/2007)|
|8.||Bhandari, Vineet: 8 articles (01/2014 - 05/2007)|
|9.||Reiss, Yvonne: 7 articles (07/2015 - 02/2006)|
|10.||Giamarellos-Bourboulis, Evangelos J: 7 articles (01/2014 - 11/2008)|
03/15/2013 - "Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy."
08/01/2015 - "Angiopoietin-2 (Ang-2) blocking agents are currently undergoing clinical trials for use in cancer treatment. "
01/01/2015 - "Angiogenesis plays a decisive role in the growth and spread of cancer and angiopoietin-2 (Ang2) is in the spotlight of studies for its unique role in modulating angiogenesis. "
08/15/2015 - "Lower baseline levels of angiopoietin-2 were suggestive of tumor response and longer PFS. "
05/01/2015 - "Angiopoietin 2 (ANGPT2) is a crucial factor regulating tumor angiopoiesis. "
06/01/2012 - "Fluid conservative therapy preferentially lowers plasma angiopoietin-2 levels over time and thus may be beneficial in part by decreasing endothelial inflammation."
07/01/2015 - "Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation."
12/01/2013 - "Angiopoietin-2 generally has an opposing action, and is released naturally at times of vascular growth and inflammation. "
09/01/2013 - "Angiopoietin-2 (Angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation. "
07/01/2012 - "Angiopoietin-2 (ang-2) that activates endothelial cells and increases vascular inflammation might have significant roles in the pathogenesis of glomerular diseases. "
10/01/2014 - "Manifestations of sepsis were also attenuated in distant organs, including the kidney, where renal function was improved without affecting local angiopoietin-2 production. "
10/01/2014 - "Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis."
07/01/2015 - "Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis."
05/01/2015 - "Angiopoietin-2 (Ang-2) is an important mediator in sepsis. "
10/01/2014 - "The Tie2 antagonist angiopoietin-2 represents a promising target against sepsis-associated multiple organ dysfunction. "
|4.||Macular Degeneration (Age-Related Maculopathy)
09/04/2015 - "Here, we engineered a Two-in-One VEGF/angiopoietin 2 antibody with dual action Fab (DAF) as a potential therapeutic for neovascular age-related macular degeneration. "
01/01/2012 - "The aim of this study was to investigate the levels of pigment epithelium-derived factor (PEDF), angiopoietin 2, vascular endothelial growth factor (VEGF), and soluble VEGF receptor 1 (sVEGFR-1) in vitreous samples of patients suffering from age-related macular degeneration with choroidal neovascularization or from proliferative diabetic retinopathy (PDR). "
|5.||Systemic Scleroderma (Systemic Sclerosis)
04/01/2011 - "Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease."
09/01/2013 - "Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis."
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||glucuronyl glucosamine glycan sulfate (Vessel)
|5.||Messenger RNA (mRNA)
|6.||TIE-2 Receptor (Receptor, TIE 2)
|7.||Biological Markers (Surrogate Marker)
|8.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|10.||Proteins (Proteins, Gene)
|1.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)
|5.||Homologous Transplantation (Allograft)